1-20 of 39
Authors: Hector Mendez-Gomez
Journal Article
CNSC-17. UPREGULATION OF CCL4 AFTER TREATMENT WITH A NOVEL MRNA VACCINE SHIFTS THE PHENOTYPE OF CCR5-EXPRESSING MICROGLIA WITHIN TUMOR MICROENVIRONMENT
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii44, https://doi.org/10.1093/neuonc/noae165.0173
Published: 11 November 2024
Journal Article
IMMU-31. DAMAGE RESPONSE FROM SYSTEMIC RNA VACCINATION RESTORES HUMORAL IMMUNITY IN GLIOBLASTOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii159, https://doi.org/10.1093/neuonc/noae165.0624
Published: 11 November 2024
Journal Article
EXTH-58. BLOCKING IMMUNE CHECKPOINT— LAIR1: DISRUPTING THE LAIR1—FXIII-A—COLLAGEN IMMUNOSUPPRESSIVE CIRCUIT FOR ENHANCED ANTITUMOR THERAPEUTICS
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii250, https://doi.org/10.1093/neuonc/noae165.0989
Published: 11 November 2024
Journal Article
IMMU-63. MESSENGER RNA CHALLENGE PREDICTS CANCER IMMUNOGENICITY AND RESPONSE TO CHECKPOINT INHIBITORS
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii166–viii167, https://doi.org/10.1093/neuonc/noae165.0655
Published: 11 November 2024
Journal Article
EXTH-76. REDIRECTING STROMAL CELLS TO IGNITE ANTI-TUMOR IMMUNITY AGAINST GLIOBLASTOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii254, https://doi.org/10.1093/neuonc/noae165.1006
Published: 11 November 2024
Journal Article
EXTH-09. GENE MODIFICATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS FOR IMPROVEMENT OF IMMUNOTHERAPIES FOR MALIGNANT GLIOMAS
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii238, https://doi.org/10.1093/neuonc/noae165.0940
Published: 11 November 2024
Journal Article
DIPG-18. MULTIMODALITY VISUALIZATION OF A PRECLINICAL MODEL OF DIFFUSE MIDLINE GLIOMA DEMONSTRATES CLEAR TREATMENT EFFECT AFTER RNA NANOPARTICLE THERAPY
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.071
Published: 18 June 2024
Journal Article
EXTH-22. AN IND-ENABLED STUDY USING A NOVEL CHECKPOINT BLOCKADE OF LAIR1 FOR GLIOBLASTOMA THERAPY
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v228, https://doi.org/10.1093/neuonc/noad179.0875
Published: 10 November 2023
Journal Article
CNSC-30. CD4 T CELLS MEDIATED UPREGULATION OF CCL4 CHEMOKINE DRIVES GLIOBLASTOMA TUMOR MICROENVIRONMENT REPROGRAMMING FOLLOWING TREATMENT WITH A NOVEL MRNA VACCINE
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v29, https://doi.org/10.1093/neuonc/noad179.0114
Published: 10 November 2023
Journal Article
IMMU-20. MESSENGER RNA CHALLENGE RAPIDLY PREDICTS BRAIN TUMOR RESPONSIVENESS TO CHECKPOINT INHIBITORS
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v145–v146, https://doi.org/10.1093/neuonc/noad179.0552
Published: 10 November 2023
Journal Article
CTIM-11. MRNA AGGREGATES ELICIT RAPID IMMUNOLOGIC RESPONSE AND PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v63, https://doi.org/10.1093/neuonc/noad179.0251
Published: 10 November 2023
Journal Article
EXTH-35. UNRAVELING THE MECHANISTIC UNDERPINNINGS OF MRNA VACCINE MEDIATED INNATE IMMUNE ACTIVATION AND LYMPHOCYTE TRAFFICKING FOR HIGH-GRADE GLIOMAS
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v231–v232, https://doi.org/10.1093/neuonc/noad179.0888
Published: 10 November 2023
Journal Article
IMMU-06. SYSTEMIC MRNA VACCINES RESET IMMUNOGENICITY AGAINST DIFFUSE MIDLINE GLIOMA
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i50, https://doi.org/10.1093/neuonc/noad073.193
Published: 12 June 2023
Journal Article
EXTH-46. RNA LIPID PARTICLES INDUCE BI-DIRECTIONAL IMMUNITY AGAINST DIFFUSE MIDLINE GLIOMA
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii219, https://doi.org/10.1093/neuonc/noac209.844
Published: 14 November 2022
Journal Article
EXTH-92. TARGETING PRIMARY CENTRAL NERVOUS SYSTEM B CELL LYMPHOMA IGH CLONOTYPES USING NOVEL RNA-NPS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii230–vii231, https://doi.org/10.1093/neuonc/noac209.890
Published: 14 November 2022
Journal Article
DDDR-29. THE HYDROGEL-CXCL9-MRNA (HCM) VACCINE RESULTS IN SIGNIFICANT ANTI-TUMOR EFFICACY THROUGH RECRUITMENT OF NATURAL KILLER (NK) CELLS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii105, https://doi.org/10.1093/neuonc/noac209.394
Published: 14 November 2022
Journal Article
EXTH-57. IDENTIFICATION OF NOVEL IMMUNE CHECKPOINT MOLECULE IN GLIOMA, LAIR1
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii222, https://doi.org/10.1093/neuonc/noac209.855
Published: 14 November 2022
Journal Article
SURG-01. DEVELOPMENT OF MURINE MODEL OF LASER INTERSTITIAL THERMOTHERAPY (LITT) FOR BRAIN TUMORS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii251, https://doi.org/10.1093/neuonc/noac209.967
Published: 14 November 2022
Journal Article
IMMU-33. CCL4 DRIVES GLIOBLASTOMA (GBM) TUMOR MICROENVIRONMENT (TME) REPROGRAMMING AFTER TREATMENT WITH A NOVEL MRNA VACCINE
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii138, https://doi.org/10.1093/neuonc/noac209.530
Published: 14 November 2022
Journal Article
CTIM-28. MULTILAMELLAR MRNA LIPID PARTICLES INDUCE IMMUNOLOGIC REPROGRAMMING IN CANINE AND HUMAN GLIOBLASTOMA PATIENTS
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii66–vii67, https://doi.org/10.1093/neuonc/noac209.260
Published: 14 November 2022
